Oxidative Stress and Acute-Phase Response Status During Treatment in Premature Calves with Respiratory Distress Syndrome

dc.authoridTras, Bunyamin/0000-0001-9122-8059
dc.contributor.authorOk, M.
dc.contributor.authorYildiz, R.
dc.contributor.authorTras, B.
dc.contributor.authorCoskun, P.
dc.contributor.authorAkar, A.
dc.date.accessioned2024-09-18T20:55:46Z
dc.date.available2024-09-18T20:55:46Z
dc.date.issued2021
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractThis study aimed to determine lipid peroxide (LPO), antioxidant capacity (AOC), and acute-phase protein changes before and after different nebulization treatments in premature calves with respiratory distress syndrome (RDS). Thirty-six premature calves were divided into equal number of 6 groups. Group 1 was labelled as negative control and received standard treatment. Group 2 was labelled as positive control; Groups 3, 4, 5, and 6 were labelled as trial groups. These groups received nebulizer treatment. Nebulizer drug combinations were as follows: Group 2 (fluticasone), Group 3 (formoterol + fluticasone), Group 4 (ipratropium bromide + fluticasone), Group 5 (fluticasone + furosemide) and Group 6 (formoterol + ipratropium bromide + furosemide + fluticasone). Venous blood was taken from all calves before (0 hour) and after treatment (24th, 48th, 72nd hour). It was concluded that total LPO levels gradually decreased while AOC levels increased during treatment but there was no difference in the serum amyloid A (SAA) and fibrinogen levels within groups. In conclusion, supportive and nebulizer treatments to improve function of lungs were demonstrated to alleviate oxidative stress. However, in order to reveal the effects of local nebulizer applications on oxidative stress, further studies are required to investigate oxidation parameters in the bronchoalveolar fluid.en_US
dc.description.sponsorshipScientific and Technological Research Council of Turkey (TUBITAK) [114O239]en_US
dc.description.sponsorshipThis study was supported by The Scientific and Technological Research Council of Turkey (TUBITAK) (Project No: 114O239).en_US
dc.identifier.doi10.12681/jhvms.28521
dc.identifier.endpage3256en_US
dc.identifier.issn1792-2720
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-85119676489en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage3249en_US
dc.identifier.urihttps://doi.org/10.12681/jhvms.28521
dc.identifier.urihttps://hdl.handle.net/20.500.12483/12039
dc.identifier.volume72en_US
dc.identifier.wosWOS:000713498000031en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherHellenic Veterinary Medical Socen_US
dc.relation.ispartofJournal of The Hellenic Veterinary Medical Societyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectrespiratory distress syndromeen_US
dc.subjectpremature calfen_US
dc.subjectoxidative stress markersen_US
dc.subjectacute-phase responseen_US
dc.titleOxidative Stress and Acute-Phase Response Status During Treatment in Premature Calves with Respiratory Distress Syndromeen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
650.05 KB
Biçim:
Adobe Portable Document Format